January 30, 2019
Immunogenicity and Safety Study of 1 and 2 Doses of GlaxoSmithKline (GSK) Biologicals’ Meningococcal Vaccine MenACWY-TT (GSK134612) in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration With Pfizer’s Prevenar 13™Vaccine
Read More
January 30, 2019
Belimumab in Remission of VASculitis
Read More
January 30, 2019
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
Read More
January 30, 2019
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
Read More
January 30, 2019
Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer
Read More
January 30, 2019
Everolimus Post Pazopanib Treatment in Metastatic or Advanced Renal Cell Carcinoma
Read More
January 30, 2019
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC
Read More
January 30, 2019
Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies
Read More
January 30, 2019
Phase 3 Study of Sofosbuvir and Ribavirin
Read More
January 30, 2019
Phase 3 Study of Sofosbuvir and Ribavirin
Read More
January 30, 2019
Gilead Sustained Virologic Response (SVR) Registry
Read More
January 30, 2019
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Read More
Load More
X